Scott Plotkin, MD, PhD, is the Armenise Family Professor of Neurology at Harvard Medical School and is the Executive Director of Stephen E. and Catherine Pappas Center for Neuro-Oncology at Massachusetts General Hospital. Dr. Plotkin’s research focuses on developing novel treatments for persons with NF1, NF2, and schwannomatosis. He has served as principal investigator on multi-center clinical trials and is an active member of several national consortia. In 2011, he co-founded the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.
